Get the Stockscreener App
20.28
1.15%
0.23
Overview
News
Price History
Option Chain
Why FMS Down?
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $20.28, with a volume of 156.91K.
It is up +1.15% in the last 24 hours and down -2.03% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
See More
Previous Close:
$20.05
Open:
$19.94
24h Volume:
156.91K
Relative Volume:
0.55
Market Cap:
$11.84B
Revenue:
$21.01B
Net Income/Loss:
$572.69M
P/E Ratio:
24.87
EPS:
0.8156
Net Cash Flow:
$2.10B
1W Performance:
-0.54%
1M Performance:
-2.03%
6M Performance:
-3.29%
1Y Performance:
+16.35%
1-Day Range:
$19.89
$20.32
1-Week Range:
$18.94
$20.32
52-Week Range:
$16.66
$22.76
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
| Aug-14-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Resumed | Citigroup | Neutral |
| Jul-12-23 | Initiated | Goldman | Buy |
| Mar-07-23 | Initiated | Bernstein | Mkt Perform |
| Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
| Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
| Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
| Nov-23-21 | Initiated | HSBC Securities | Hold |
| Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
| Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-26-18 | Upgrade | UBS | Neutral → Buy |
| Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
| Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-04-18 | Upgrade | UBS | Sell → Neutral |
| Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
| Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
| Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
| Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-02-13 | Reiterated | Feltl & Co. | Hold |
| Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Fresenius Medical Care ADR earnings beat by $0.35, revenue fell short of estimates - Investing.com
Weekly Upgrades and Downgrades - InvestorPlace
Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - GlobeNewswire Inc.
FMS Stock Rides on Diversified Portfolio and Restructuring Initiatives - Benzinga
FMS Stock Rides On Diversified Portfolio And Restructuring Initiatives - Barchart
Canada Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
Expert Call - Fresenius Medical Care
Earnings call: Fresenius Medical Care sees steady progress in Q2 - Investing.com
Earnings call: Fresenius Medical Care confirms outlook, reports growth - Investing.com
Fresenius Medical Care Aims to Improve Its Margins Substantially - Morningstar
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 - Fresenius Medical Care
UK Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Singapore Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Italy Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Fresenius Medical Care celebrates 50th anniversary of St. Wendel site - Fresenius Medical Care
Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal ... - GlobeNewswire Inc.
Fresenius Medical Care: Significant Upside Remains (NYSE:FMS) - Seeking Alpha
Fresenius Medical Care (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com - Defense World
Fresenius Medical Care AG (NYSE:FMS) Shares Acquired by GAMMA Investing LLC - Defense World
Fresenius Medical Care (NYSE:FMS) Sees Unusually-High Trading Volume - Defense World
Fresenius Medical Care AG (NYSE:FMS) Receives $24.00 Consensus Target Price from Brokerages - MarketBeat
Fresenius Medical Care AG (NYSE:FMS) Receives Consensus Rating of “Hold” from Brokerages - Defense World
Fresenius Medical's (FMS) Q4 Earnings and Revenues Beat - Yahoo Sport Australia
New Strong Sell Stocks for January 9th - Yahoo News Australia
Why Fresenius (FMS) is a Top Value Stock for the Long-Term - Yahoo News Malaysia
Fresenius Medical Care (NYSE:FMS) Sees Large Volume Increase - MarketBeat
Fresenius Medical Care (ETR:FME) Share Price Crosses Above Two Hundred Day Moving Average of $37.39 - Defense World
Fresenius Medical Care (NYSE:FMS) Shares Gap Down to $20.62 - Defense World
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.36%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):